THE LEVEL OF A NUMBER OF MARKERS OF MYOCARDIAL DYSFUNCTION IN BLOOD PLASMA IN CASE OF ANTHRACYCLINE-MEDIATED CARDIOTOXICITY IN CANCER PATIENTS
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.
Details